Our results confirm the involvement of IL-2 in RA at higher rates compared to a French cohort (39% vs.15%, respectively)26 and is mirrored by a concomitant positivity to peptide antigens derived from EBV, HERV-K, MAP or human IRF5. Here, IRF5 is linked to rheumatoid arthritis.